VT
AMED

Vise Technologies’s Amedisys AMED Stock Holding History

Vise Technologies’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-17,228
Closed -$1.7M – 1183
2025
Q2 		$1.7M Buy
+17,228
New +$1.63M 0.07% 304
2024
Q4 		$248K Buy
+2,727
New +$250K 0.02% 685
2023
Q4 		– Sell
-2,231
Closed -$208K – 350
2023
Q3 		$208K Sell
2,231
-966
-30% -$89.3K 0.05% 312
2023
Q2 		$292K Sell
3,197
-1,722
-35% -$141K 0.07% 247
2023
Q1 		$362K Sell
4,919
-282
-5% -$24.4K 0.1% 215
2022
Q4 		$434K Buy
5,201
+2,486
+92% +$224K 0.14% 172
2022
Q3 		$263K Buy
+2,715
New +$324K 0.1% 233
2022
Q2 		– Sell
-1,632
Closed -$281K – 295
2022
Q1 		$281K Buy
+1,632
New +$244K 0.11% 178

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Vise Technologies's AMED Position: Q3 2025 in Review

Vise Technologies sold out of Amedisys (AMED) in Q3 2025, closing a stake of 17,228 shares — an estimated $1.7M sold.

Vise Technologies first reported a position in AMED in Q1 2022 and held it in 8 quarters. The position peaked at $1.7M in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Vise Technologies reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Vise Technologies sold 17,228 Amedisys shares in Q3 2025, an estimated $1.7M.
  • Vise Technologies first reported a position in Amedisys in Q1 2022 and held it in 8 quarters.
  • Vise Technologies's Amedisys position peaked at $1.7M in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Vise Technologies's 13F filing for Q3 2025, filed 13 Nov 2025.